+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Microrna"

From
From
From
From
From
From
From
From
RNA Interference Therapy-Competitive landscape, 2023 - Product Thumbnail Image

RNA Interference Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
From
MicroRNA Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

MicroRNA Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
RNA Sequencing Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

RNA Sequencing Market - Forecasts from 2021 to 2026

  • Report
  • November 2021
  • 123 Pages
  • Global
From
Antisense and RNAi Therapeutics Market - Product Thumbnail Image

Antisense and RNAi Therapeutics Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Epigenomics Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Epigenomics Market - Global Forecast Report 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
Loading Indicator

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools. Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more